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ABSTRACT
Purpose: Trachoma is endemic in parts of Nepal; implementation of the surgery, antibiotics, facial
cleanliness, environmental improvement (SAFE) strategy started in 2002. Some suspected-ende-
mic districts had not previously been mapped. We aimed to estimate the prevalences of tracho-
matous inflammation—follicular (TF) and trichiasis in those districts.
Methods: Population-based prevalence surveys were undertaken in 27 districts. In each of those
districts, two-stage cluster sampling was used to select a sample of 2000 children aged 1–9 years
and 4000 adults aged ≥15 years from a total of 40 wards (clusters), drawn evenly from two
subdistricts. Consenting eligible participants were examined for trachoma by Global Trachoma
Mapping Project (GTMP)-certified graders, using the World Health Organization simplified grading
system. Data were analyzed at district level using GTMP methods.
Results: A total of 43,200 households were surveyed, and 162,094 people were examined for
trachoma. District-level TF prevalence in 1–9-year-olds ranged from 0% to 4.3% (95% confidence
interval [CI] 2.4–6.2). Among adults aged ≥15 years, trichiasis prevalence ranged from 0% to 0.33%
(95% CI 0.08–0.65).
Conclusion: TF was not a public health problem in any of the 27 districts surveyed; thus, antibiotic
mass drug administration is not needed. In two districts (Dhanusa and Gorkha), trichiasis pre-
valence in adults aged ≥15 years was ≥0.2%; thus, further trichiasis surgery interventions at public
health level are warranted to achieve elimination. These findings will facilitate planning for
elimination of trachoma as a public health problem in Nepal.
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Background
Trachoma, a neglected tropical disease, remains a preven-
table cause of blindness. Its elimination as a public health
problem (through the surgery, antibiotics, facial cleanliness,
and environmental improvement: “SAFE” strategy) is a
global target that was endorsed by the World Health
Assembly in 1998.1,2 The World Health Organization
(WHO) estimates that by 2016 a total of 190.2 million
people worldwide required A, F, and E for trachoma elim-
ination purposes, in 42 countries.3 It has been estimated
that 1.9 million people are blind or visually impaired from
it; 3.2 million people need surgery to avoid trachomatous
blindness.4 Prior to SAFE implementation, baseline surveys
of trachoma prevalence are recommended to guide pro-
grams to deliver appropriate interventions.5
Three decades ago, trachoma was considered the
most widespread potentially blinding disease in Nepal,
affecting 6.5% of the population and accounting for 2.4%
of bilateral blindness nationally.6 Trachoma was charac-
terized as hyperendemic in the western districts, and
there were thought to be over 58,000 people with
trichiasis.6 The National Trachoma Program (NTP), in
collaboration with partners, started implementation of
the SAFE strategy in 2002. The first step involved under-
taking trachoma rapid assessments (TRAs).7 In districts
where TRA results showed that ≥10% of 1–9 year-olds
examined had trachomatous inflammation—follicular
(TF), population-based prevalence surveys (PBPSs)
were subsequently undertaken.8
The Ministry of Health and Population in Nepal
initially set itself the goal to eliminate trachoma as a
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public health problem by the year 2017. By 2012, Nepal
had done PBPSs of trachoma in 27 out of 75 districts,
of which 20 districts were under implementation of the
SAFE strategy.9 However, eight districts that had not
been mapped previously were suspected to be endemic
for trachoma. Additionally, districts that previously had
TRAs (14) and PBPSs (five) were felt to need further
PBPSs because initial findings had indicated the per-
centage of children having TF in the 5–9.9% range. In
the series of surveys described here, we aimed to esti-
mate the prevalence of TF and trichiasis in 27 districts,
where trachoma was still suspected to be endemic, and
in which trachoma-specific interventions had not pre-
viously been undertaken.
Materials and methods
Study settings
Figure 1 shows the location of the 27 districts where
surveys were conducted in 2013 (14 districts) and 2014
(13 districts). Among the 27 districts, 8 districts had not
been surveyed, while 19 had previously been evaluated
with either a TRA or a PBPS (between 1996 and 2012) and
found to have a TF proportion or prevalence of 5–9.9%.
Survey design and sampling
These surveys were designed prior to the start of the
Global Trachoma Mapping Project (GTMP), and their
methodology therefore differs from the GTMP
template10 in several ways, notably: (1) the sample for
each district was fixed as 2000 children aged 1–9 years
and 4000 adults aged ≥15 years, instead of a fixed
sample of households; (2) the water and sanitation
fields in the household questionnaire were not the
GTMP standardized questions (so these data have not
been included in this analysis); and (3) data were col-
lected using paper-based questionnaires instead of the
GTMP’s Android smartphone-based system.
Surveys were powered to estimate a district-level TF
prevalence of 4% in 1–9-year-olds, aiming to have
95% confidence of estimating that prevalence with
absolute precision of ± 2% and a (conservative) design
effect of 5, which resulted in a sample size estimate of
1844 children aged 1–9 years; we rounded this up to
2000. In addition, the sample size for adults aged ≥15
years was powered to estimate a trichiasis prevalence
of 1.0% with an absolute precision of 0.5% and a
design effect of 2.6, which resulted in a sample of
3926 (rounded up to 4000). The smallest administra-
tive area (the ward) was defined as a cluster. To obtain
the desired sample, each district was stratified into two
subdistricts and 40 wards (20 per subdistrict) were
systematically selected with probability proportional
to population size, using census data from 2011 to
generate the sampling frame. In each cluster, house-
holds were sampled using the random walk method5
to obtain a fixed sample of 50 children aged 1–9 years
and 100 adults aged ≥15 years.
Trachoma grading
Graders participating in the surveys had obtained a
kappa for diagnosing TF of ≥0.7 based on an intergra-
der agreement test, compared to a GTMP-certified
grader trainer as the gold standard.11 The eyelid and
tarsal conjunctiva of each eye were examined for the
trachoma signs TF and trichiasis, using the definitions
of the WHO simplified grading system12, a 2.5 × magni-
fying loupe, and torch or sunlight.
Figure 1. Map of Nepal showing districts previously surveyed (in 1996–2012) and districts surveyed in 2013–2014.
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Data collection
Survey teams composed of four people (a grader, an
enumerator, a community health volunteer, and a helper)
undertook the fieldwork, covering, on average, one cluster
per day. After obtaining verbal consent, household mem-
bers were enumerated and examined for trachoma signs.
Data management and analysis
Data collection was done using paper-based question-
naires, after which data were double entered and
validated for accuracy. Descriptive statistics were
used to examine sample characteristics. Prevalence
estimates and 95% confidence intervals for TF and
trichiasis were generated using GTMP methods in R
(R Foundation for Statistical Computing, Vienna,
Austria) and structured query language. For each
cluster, the proportion of 1–9-year-olds with TF was
adjusted for age, using data from the most recent
census. Similarly, for each cluster, the proportion of
≥15-year-olds with trichiasis was adjusted for gender
and age in 5-year age bands.10 District-level preva-
lences of TF and trichiasis were calculated as the
means of the adjusted cluster-level proportions, and
confidence intervals for each of these prevalence esti-
mates were calculated by bootstrapping, with replace-
ment, over 10,000 replications.
Ethics statement
The survey was carried out by the NTP. Ethical clearance
was obtained from the Institutional Review Board of
Nepal Netra Jyoti Sangh and Nepal Health Research
Council. Verbal informed consent was sought from par-
ents/guardians for children aged 1–9 years, and from each
participant aged ≥15 years. Children with TF were treated
with 1% tetracycline ointment, with tubes being given to
carers to apply twice daily for 6 weeks. Individuals with
trichiasis were counseled and referred to hospitals, where
trichiasis surgery was offered free of charge.
Results
Characteristic of the sample
Table 1 shows the demographic characteristics of the
sample in 27 districts surveyed. A total of 43,200
households were visited and 162,094 people were
examined for trachoma. Examinees included 54,041
children aged 1–9 years and 108,053 adults aged
≥15 years. The proportion of female participants was
47.4% among children aged 1–9 years and 53.2%
among those aged ≥15 years. The mean (standard
deviation) age was 5.5 (2.6) and 36.2 (16.7) years
among children aged 1–9 years and adults aged
≥15 years, respectively.
Table 1. Characteristics of survey population, population-based trachoma surveys, Nepal, 2013–2014.
Children aged 1–9 years Adults aged ≥15 years
Region District Survey year Number examined Proportion female (%) Number examined Proportion female (%)
Central Dhanusha 2013 2,000 44.2 4,000 48.5
Central Sindhuli 2013 2,000 47.2 4,000 56.5
East Bohjpur 2013 2,000 46.8 4,000 52.5
East Ilam 2013 2,000 48.7 4,000 50.5
East Morang 2013 2,000 55.5 4,000 53.9
East Panchthar 2013 2,000 47 4,000 50.6
East Saptari 2014 2,000 47.4 4,000 58.9
East Shankhuwasava 2013 1,997 43.8 4,000 49.17
East Sunsari 2013 2,000 43.4 4,000 48.5
East Taplejung 2013 2,000 48.6 4,000 50.8
Far west Baitadi 2013 1,999 39.7 3,999 50.8
Far west Bajhang 2014 2,050 49 4,100 55.6
Far west Dadeldhura 2014 2,004 46.5 3,993 55
Far west Darchula 2014 2,002 47.8 3,993 50.1
Midwest Dolpa 2014 2,000 46.5 3,999 47.7
Midwest Pyuthan 2013 2,002 51.3 3,993 50.8
Midwest Salyan 2013 2,000 48.4 3,999 57.1
West Arghakhanchi 2013 2,000 47.1 3,985 49.8
West Baglung 2013 2,000 48.1 3,998 57.7
West Gorkha 2014 2,000 47.1 3,994 54.8
West Lamjung 2014 2,000 49.2 3,958 52.8
West Myagdi 2014 2,000 47.4 3,999 54.6
West Palpa 2014 2,000 48.9 3,995 51.2
West Parbat 2014 2,007 48.2 3,991 55.6
West Rupandehi 2014 2,000 48.5 3,995 50.5
West Syanja 2014 2,005 45.8 3,994 58.2
West Tanahun 2014 1,975 46.9 4,068 63.1
Total 54,041 47.4 108,053 53.2
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Prevalence of trachoma signs
Table 2 summarizes the prevalence of TF and trichia-
sis by district. Prevalence of TF in children aged
1–9 years ranged (by district) from 0% to 4.3%
(95% confidence interval [CI] 2.4–6.2), while trichia-
sis prevalence in adults aged ≥15 years ranged from
0% to 0.33% (95% CI 0.08–0.65). Trichiasis preva-
lence was ≥0.2% in two districts. Prevalence cate-
gories are shown in Figure 2, alongside those
generated at baseline in districts of Nepal that were
surveyed prior to this tranche of work.
Discussion
Baseline trachoma surveys are essential for planning
implementation of the SAFE strategy and setting targets
for elimination. This set of surveys completes baseline
mapping of suspected-endemic districts in Nepal, and
showed that trachoma was not a public health problem
in 25 of 27 districts for which we generated data. The
prevalence of TF among children aged 1–9 years was
< 5% in all districts, and only two districts (Dhanusha
and Gorkha) had trichiasis prevalence of ≥0.2% in
adults aged ≥15 years, indicating a requirement for
public health-level trichiasis surgery programs to
achieve the trichiasis elimination target.13 Following
intervention, further prevalence surveys of trichiasis
will be needed to document attainment of
elimination.14
Our survey design’s major strength was the over-
sampling compared to the most recent sample sizes
recommended by the WHO for both TF (1019 children
aged 1–9 years)10 and trichiasis (2818 adults aged
≥15 years)15, which thus provided power for very pre-
cise prevalence estimates at district level. However,
there are a number of potential limitations. First, the
use of a fixed sample of 50 children and 100 adults per
cluster is a potential source of (albeit minor) bias, since
examinees were recruited by selecting households, not
individuals, and it is unlikely that the group of house-
holds chosen in every cluster yielded exactly the desired
number of examinees in each age group. Second, sam-
pling of households was done using the random walk
method; this is not optimally rigorous from an epide-
miological perspective. Third, we did not check to see
whether cases of trichiasis were associated with tracho-
matous scar of the conjunctiva, which was a recom-
mendation made in 2015,16 well after these surveys
were completed. Finally, the water and sanitation data
that we collected were not translatable to WHO/
UNICEF Joint Monitoring Program definitions for
improved and unimproved water sources and sanita-
tion facilities (https://www.wssinfo.org/definitions-
Table 2. Prevalence of TF among children aged 1–9 years and trichiasis among adults aged ≥15 years, Nepal,
2013–2014.
Region District
Prevalence of TF % in children
1–9 years (95% CI)a
Prevalence of trichiasis % in
adults ≥15 years (95% CI)b
Central Dhanusha 0 0.21 (0.02–0.48)
Central Sindhuli 0.2 (0.0–0.3) 0.02 (0.0–0.04)
East Bhojpur 0.1 (0.0–0.2) 0.03 (0.0–0.06)
East Ilam 0 0
East Morang 0.3 (0.1–0.5) 0.09 (0.01–0.19)
East Panchthar 0 0
East Saptari 0.1 (0.0–0.1) 0
East Shankhuwasava 0.2 (0.0–0.3) 0
East Sunsari 0.5 (0.0–1.2) 0.02 (0.0–0.04)
East Taplejung 0.3 (0.0–0.6) 0
Far west Baitadi 4.5 (1.4–9.4) 0
Far west Bajhang 0 0.05 (0.0–0.09)
Far west Dadeldhura 0.4 (0.0–0.8) 0.11 (0.01–0.27)
Far west Darchula 0.2 (0.0–0.4) 0.11 (0.01–0.22)
Midwest Dolpa 0.1 (0.0–0.1) 0
Midwest Pyuthan 0 0
Midwest Salyan 4.3 (2.4–6.2) 0.12 (0.04–0.21)
West Arghakhanchi 0 0
West Baglung 0.2 (0.0–0.4) 0
West Gorkha 0.7 (0.1–1.1) 0.33 (0.08–0.65)
West Lamjung 0.6 (0.0–1.5) 0.05 (0.0–0.13)
West Myagdi 0.1 (0.0–0.2) 0.01 (0.0–0.01)
West Palpa 0 0
West Parbat 0.3 (0.0–0.6) 0
West Rupandehi 0 0
West Syanja 0.2 (0.0–0.4) 0.01 (0.0–0.03)
West Tanahun 0.1 (0.0–0.2) 0.07 (0.0–0.17)
aAdjusted for age in 1-year age bands (see text).
bAdjusted for gender and age in 5-year age bands (see text).
CI, confidence interval.
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methods/watsan-categories/), and we have therefore
not presented them here. We do not believe that this
weakens our conclusions: any comparison of TF and
access to water and sanitation would be moot, given
that TF prevalence was < 5% in each district.
The findings from these surveys suggest that TF
was not a public health problem in any of 27 dis-
tricts, so antibiotic mass drug administration will not
be needed for trachoma elimination. However, two
districts need to undertake public-health-level trichia-
sis surgery interventions to attain elimination of tra-
choma. The data suggest that with intensive effort
and a small number of further prevalence surveys,
Nepal may soon be able to eliminate trachoma and
demonstrate that this has been achieved.
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Figure 2. Baseline prevalence of TF in children aged 1–9 years and trichiasis in adults aged ≥15 years, Nepal, 1996–2014. (a) TF
prevalence from districts mapped in 1996–2012; (b) TF prevalence from districts mapped in 2013–2014; (c) TF prevalence combining
data from all surveys conducted in 1996–2014; (d) Trichiasis prevalence from districts mapped in 1996–2012; (e) Trichiasis prevalence
from districts mapped in 2013–2014; (f) Trichiasis prevalence combining data from all data surveys conducted in 1996–2014.
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